M. Udayabanu

In silico identification of edible mushroom-derived dual cholinesterase inhibitors as potential therapeutic candidates for Alzheimer's Disease

Findings indicate that mushroom-derived sterols may serve as promising lead compounds for the development of novel therapeutics against AD, however, further validation through molecular dynamics simulations, in vitro assays, and in vivo studies is necessary to confirm their efficacy, stability, and therapeutic potentia...